Pre-Clinical (Discovery and Development)
Find out how to fill up your pipeline and increase innovation. Pharma IQ is proud to provide an international, non-biased, central resource, for professionals working in early discovery and preclinical research to exchange ideas on best practice and share case studies on innovation within the area.
Three ways AI is speeding up drug discovery
July 08 by Leila HawkinsPharma IQ look’s at how Bristol Myers Squibb, Janssen and Sanofi are using AI in drug discovery
Reducing the drug discovery life cycle with AI
July 05 by Leila HawkinsWe find out how Recursion Pharmaceuticals is reducing the drug discovery life cycle with AI
How AI is making drug discovery safer and faster
June 24 by Leila HawkinsWe find out how Sanofi is using AI to predict the toxicity of drugs earlier in the discovery phase
New nanochannels could make next-gen drug discovery more efficient
June 21 by Leila HawkinsResearchers develop new technique to study biomolecules on the nanoscale
CRISPR therapy could offer one-time cure for sickle cell disease
June 20 by Leila HawkinsCRISPR therapy shows promise as a cure for severe sickle cell disease
How Sanofi is using AI to accelerate time to market for new drugs
June 06 by Leila HawkinsLearn more about how AI can accelerate the drug discovery process
Pharma prepares to fight global monkeypox outbreak
May 23 by Leila HawkinsPharma companies react to the world’s latest viral outbreak
How to use automation to accelerate drug discovery and delivery
May 23 by Pharma IQFind out how leading biopharma companies are using lab automation for drug discovery and development
The benefits of drug reformulation
May 13 by Leila HawkinsPharma IQ finds out about the advantages of drug reformulation to develop medication that serves unmet needs
How to use connected innovation intelligence for drug discovery and development
May 12 by Pharma IQThis white paper explores how AI-powered connected innovation intelligence can be effective for drug discovery
The latest in cancer treatments: Recreating the tumor environment
April 28 by Leila HawkinsPharma IQ speaks to HCS Pharma about creating the technology that reproduces tumor microenvironments to treat cancer
AstraZeneca shares positive results for its drug to lower cholesterol
April 13 by Leila HawkinsPharma IQ speaks to AstraZeneca about its promising new drug candidate to tackle one of the world’s leading causes of death